Biomerica (NASDAQ:BMRA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

Shares of Biomerica, Inc. (NASDAQ:BMRAGet Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.47 and traded as high as $0.55. Biomerica shares last traded at $0.54, with a volume of 76,444 shares changing hands.

Biomerica Trading Up 4.2 %

The stock has a market capitalization of $9.81 million, a price-to-earnings ratio of -1.57 and a beta of 0.37. The company has a fifty day moving average of $0.66 and a two-hundred day moving average of $0.47.

Biomerica (NASDAQ:BMRAGet Free Report) last posted its earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC lifted its position in Biomerica, Inc. (NASDAQ:BMRAFree Report) by 24.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the quarter. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 22.28% of the company’s stock.

Biomerica Company Profile

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Featured Articles

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.